Neurofibromatosis Type 1

What is neurofibromatosis type 1 (NF1)?

NF1 is a disorder characterized by the growth of noncancerous tumors called neurofibromas. They usually form on or just underneath the skin, as well as in the brain and peripheral nervous system. But they can also develop in other parts of the body, such as the eye.

The disorder is caused by a mutation in a gene on chromosome 17. The gene codes for a protein called neurofibromin. This protein regulates the activity of another protein called ras, which promotes cell division. When the NF1 gene is mutated, it usually leads to a shortened version of the neurofibromin protein that cannot bind to ras or regulate its activity. As a result, the ras protein is more active. Cells are told to begin dividing and never told when to stop, causing the formation of tumors.

How do people get NF1?

In about half of all cases, a person inherits the mutated gene from a parent. The disorder is inherited in an autosomal dominant pattern, which means that only one copy of the defective gene has to be inherited for a child to get the disorder. Each child of a parent with NF1 runs a 50 percent risk of getting the disorder.

In the other half of NF1 cases, a person will have no family history of the disease. The mutation is new and has likely occurred early in life (during the development of the embryo). The mutation will not be present in every cell of the person's body, just in some of them. But if it does happen to be in the germ cells (egg or sperm), the person can pass it on to their children. New mutations are so frequently the cause of NF1 because the NF1 gene is very large, making it more likely to accrue mutations.

What are the symptoms of NF1?

The severity and physical signs of NF1 can vary widely from patient to patient. Most people with this disorder have very distinctive café au lait spots (the color of coffee with milk), as well as freckles. The number of café au lait spots and freckles increases with age. People with NF1 also have many noncancerous tumors called neurofibromas throughout their body. Rarely, these tumors can progress into a malignant tumor.

Others may also have high blood pressure, bone defects, scoliosis (curvature of the spine), learning disabilities, Lisch nodules (benign growths on the iris of the eye), and optic gliomas (benign tumors on the optic nerve that connects the eye to the brain).

Scientists don't know exactly why symptoms vary so much, even among people from the same family. But they predict that genetics has a lot to do with it. It is likely that each patient's unique genetic makeup influences the severity of his or her symptoms. That is, one or more additional genes other than the NF1 gene might also play a role. Scientists call these "modifier genes," and they could be any of the thousands of genes in the human genome.

How do modifier genes work? Proteins encoded by modifier genes might work in the same biological pathways as neurofibromin, and therefore affect how well these pathways work. Variations in the DNA sequence of a modifier gene may alter its function enough to influence the severity of NF1 in an individual.

To date, scientists have not found any strong candidate NF1 modifier genes.

Other factors that may contribute to the variability observed among NF1 patients are environmental events, and the different types of mutations that occur within the NF1 gene. (Over 500 different types of mutations have been observed in the NF1 gene, and all of them cause this disorder!)

How do doctors diagnose NF1?

Most of the time, the NF1 is diagnosed by its physical symptoms (tumors or café au lait spots), or by a family history of the disorder. The café au lait spots usually appear within the first two years of a child's life.

NF1 can be diagnosed by sequencing a person's NF1 gene to identify mutations. But because of the gene's large size and the high number of possible mutations that can occur, genetic testing is usually not practical - and very expensive.

Physicians usually won't recommend genetic testing for two simple reasons: a diagnosis of NF1 is fairly easy to confirm on the basis of its physical signs, and genetic testing offers no extra benefits for treatment at this time.

One exception to this is for people who have a family history of NF1. If another family member has been tested, and the mutation has been identified, then it becomes relatively easy to look for that same mutation in other family members. Finding the mutation would then confirm the diagnosis of NF1.

How is NF1 treated?

There is no cure or treatment for NF1, but surgery can remove tumors and correct malformed bones. In a very small percentage of cases, the tumors become cancerous. As in other cancers, these tumors are surgically removed and treated with chemotherapy or radiation (to kill cancer cells).

Interesting facts about NF1

People who have NF1 may have very few neurofibromas or they may have thousands of them throughout their body.

Neurofibromatosis was first described in medical literature by Dr. Friedrich von Recklinghausen. NF was called Von Recklinghausen's disease for many years.

Where can I go for more information on NF1?

Autosomal Dominant


383 Colorow Dr, Salt Lake City, Utah 84108

APA format:
Genetic Science Learning Center (2014, January 8) Neurofibromatosis Type 1. Learn.Genetics. Retrieved April 18, 2014, from
MLA format:
Genetic Science Learning Center. "Neurofibromatosis Type 1." Learn.Genetics 18 April 2014 <>
Chicago format:
Genetic Science Learning Center, "Neurofibromatosis Type 1," Learn.Genetics, 8 January 2014, <> (18 April 2014)